203 related articles for article (PubMed ID: 36497272)
1. Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour Macrophages.
Yang X; Liu X; Li J; Zhang P; Li H; Chen G; Zhang W; Wang T; Frazer I; Ni G
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497272
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC-1 tumor-bearing mice with PD-1 blockade by modulating macrophage heterogeneity and the activation of CD8
Ni G; Yang X; Li J; Wu X; Liu Y; Li H; Chen S; Fogarty CE; Frazer IH; Chen G; Liu X; Wang T
Clin Transl Immunology; 2021; 10(8):e1335. PubMed ID: 34429969
[TBL] [Abstract][Full Text] [Related]
3. Topical Application of Temperature-Sensitive Gel Containing Caerin 1.1 and 1.9 Peptides on TC-1 Tumour-Bearing Mice Induced High-Level Immune Response in the Tumour Microenvironment.
Ni G; Liu X; Li H; Fogarty CE; Chen S; Zhang P; Liu Y; Wu X; Wei MQ; Chen G; Zhang P; Wang T
Front Oncol; 2021; 11():754770. PubMed ID: 34858827
[TBL] [Abstract][Full Text] [Related]
4. Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.
Li Y; Shen Z; Chai Z; Zhan Y; Zhang Y; Liu Z; Liu Y; Li Z; Lin M; Zhang Z; Liu W; Guan S; Zhang J; Qian J; Ding Y; Li G; Fang Y; Deng H
Gut; 2023 Nov; 72(12):2307-2320. PubMed ID: 37507218
[TBL] [Abstract][Full Text] [Related]
5. Synthesized natural peptides from amphibian skin secretions increase the efficacy of a therapeutic vaccine by recruiting more T cells to the tumour site.
Pan X; Ma B; You X; Chen S; Wu J; Wang T; Walton SF; Yuan J; Wu X; Chen G; Wang Y; Ni G; Liu X
BMC Complement Altern Med; 2019 Jul; 19(1):163. PubMed ID: 31277636
[TBL] [Abstract][Full Text] [Related]
6. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
[TBL] [Abstract][Full Text] [Related]
7. Comparative Proteomic Study of the Antiproliferative Activity of Frog Host-Defence Peptide Caerin 1.9 and Its Additive Effect with Caerin 1.1 on TC-1 Cells Transformed with HPV16 E6 and E7.
Ni G; Liang D; Cummins SF; Walton SF; Chen S; Wang Y; Mounsey K; Wei MQ; Yuan J; Pan X; Liu X; Wang T
Biomed Res Int; 2018; 2018():7382351. PubMed ID: 29862288
[TBL] [Abstract][Full Text] [Related]
8. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
[TBL] [Abstract][Full Text] [Related]
9. Ataxia telangiectasia mutated kinase inhibition promotes irradiation-induced PD-L1 expression in tumour-associated macrophages through IFN-I/JAK signalling pathway.
Gao Y; Li Y; Lin Z; Zeng Y; Huang Z; Han L; Zhong Y; Gong Y; Wu Q; Xie C
Immunology; 2023 Feb; 168(2):346-361. PubMed ID: 36326481
[TBL] [Abstract][Full Text] [Related]
10. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
11. Using macrophage activation to augment immunotherapy of established tumours.
Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
[TBL] [Abstract][Full Text] [Related]
12. The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.
Xu L; Xie X; Luo Y
Eur J Cell Biol; 2021 Mar; 100(2):151153. PubMed ID: 33476912
[TBL] [Abstract][Full Text] [Related]
13. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
[TBL] [Abstract][Full Text] [Related]
14. Host-Defense Peptides Caerin 1.1 and 1.9 Stimulate TNF-Alpha-Dependent Apoptotic Signals in Human Cervical Cancer HeLa Cells.
Ni G; Chen S; Chen M; Wu J; Yang B; Yuan J; Walton SF; Li H; Wei MQ; Wang Y; Chen G; Liu X; Wang T
Front Cell Dev Biol; 2020; 8():676. PubMed ID: 32850805
[TBL] [Abstract][Full Text] [Related]
15. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
16. Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity.
Baer C; Squadrito ML; Laoui D; Thompson D; Hansen SK; Kiialainen A; Hoves S; Ries CH; Ooi CH; De Palma M
Nat Cell Biol; 2016 Jul; 18(7):790-802. PubMed ID: 27295554
[TBL] [Abstract][Full Text] [Related]
17. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
Jiang Y; Han Q; Zhao H; Zhang J
J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
[TBL] [Abstract][Full Text] [Related]
18. Iodine-125 labeled Australian frog tree host-defense peptides caerin 1.1 and 1.9 better inhibit human breast cancer cells growth than the unlabeled peptides.
Yuan J; You X; Ni G; Wang T; Cavezza S; Pan X; Liu X
Hell J Nucl Med; 2018; 21(2):115-120. PubMed ID: 30006645
[TBL] [Abstract][Full Text] [Related]
19. Tumour-associated macrophages: versatile players in the tumour microenvironment.
Ji ZZ; Chan MK; Chan AS; Leung KT; Jiang X; To KF; Wu Y; Tang PM
Front Cell Dev Biol; 2023; 11():1261749. PubMed ID: 37965573
[TBL] [Abstract][Full Text] [Related]
20. Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment.
Yang W; Yang S; Zhang F; Cheng F; Wang X; Rao J
Ann Transl Med; 2020 Mar; 8(6):399. PubMed ID: 32355843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
